Document is current
Any future updates will be listed below
-
Authors
Taoka, Toshiaki https://orcid.org/0000-0001-9227-0240
Iwamoto, Kunihiro
Miyata, Seiko
Ito, Rintaro
Kamagata, Koji
Nakamichi, Rei
Nakane, Toshiki
Iima, Mami
Fujishiro, Hiroshige
Ikeda, Masashi
Ichikawa, Kazushige
Kamiunten, Akifumi
Ichinose, Nobuyasu
Kikuta, Junko
Aoki, Shigeki
Naganawa, Shinji
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science (24K10855, 24K02402, 21K07518, 25K10859, 21H02854, 24K02381)
Agency for Medical Research and Development (23he04220250002, 24mk0101227h0003, 22wm0425008, 23tm0524001, 21wm052502, 21tm0424220h0001, 23dk0307123)
Nagoya University
- License Information
-
More Information
Article History
Received: 23 April 2025
Accepted: 9 July 2025
First Online: 24 July 2025
Declarations’
:
: T.T. and R.I. received grants from Canon Medical Systems. T.T. received JSPS KAKENHI (24K10855). R.N. and R.I. received grants from the Japan Society for the Promotion of Science. M.I. received JSPS KAKENHI (24K02402) and AMED (23he04220250002), and received grants from Himedic Nagoya. K.Iw. received funding from AMED (JP24mk0101227h0003) and JSPS KAKENHI (21K07518, 25K10859), and received honoraria from Eisai, Lundbeck Japan, Meiji Seika Pharma, MSD, Otsuka, Shionogi, Sumitomo Pharma, Takeda, Viatris, and Daiichi Sankyo. M.Ik. received funding from AMED (JP22wm0425008, JP23tm0524001, JP21wm0525024, JP21tm0424220h0001, JP23dk0307123) and JSPS KAKENHI (21H02854, 24K02381), and received speaker honoraria from Sumitomo Pharma, Eisai, Otsuka, Tanabe Mitsubishi, Mochida, Takeda, Meiji Seika Pharma, EA Pharma, Viatris, MSD, Janssen, Lundbeck, and Yoshitomi. A.K. and N.I. are employees of Canon Medical Systems Corporation. All other authors declare no conflicts of interest.
: This study was approved by the Ethics Committee of Nagoya University Graduate School of Medicine (Approval number: 2020-0352). Written informed consent was obtained from all participants prior to enrollment.
